DocDollars

Aclaris Therapeutics, Inc.

PA · United States · Reporting entity ID 100000216808

Total reported 2019–2025
$10.8M
#469 of 2,960 reporting companies — 0% of all reported industry payments
$681K in general payments across 3,236 records, plus $10.1M in research funding across 1,289 records.

How it breaks down

General payments $681,305
Research funding $10,079,021

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Aclaris Therapeutics, Inc. reported $10.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #469 of 2,960 reporting companies. 94% of that was research funding and 6% general payments such as consulting, speaking, food and travel. 3,236 general payment records and 1,289 research records were filed.

Common questions about Aclaris Therapeutics, Inc.

How much has Aclaris Therapeutics, Inc. paid US doctors?

Aclaris Therapeutics, Inc. reported $10,760,326 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $681,305 in general payments, $10,079,021 in research funding.

How does Aclaris Therapeutics, Inc. rank among drug and device companies?

It ranks #469 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Aclaris Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.